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ABSTRACT PAGE
The thyroid hormone receptor a1 (TRa) exhibits a dual role a s  an activator or 
repressor of its target genes in response to thyroid hormone (T3.) We have 
shown that TRa, formerly thought to reside solely in the nucleus bound to DNA, 
actually shuttles rapidly between the nucleus and cytoplasm. An important aspect 
of the shuttling activity of TRa is its ability to exit the nucleus through the nuclear 
pore complex. TRa export is not sensitive to treatm ent with the CRM 1-specific 
inhibitor leptomycin B (LMB) in heterokaryon assays, suggesting a possible role 
for an export receptor other than CRM1. Several groups have implicated the C a2+ 
binding protein calreticulin (CRT) in the export of TRa related proteins such as  
the glucocorticoid receptor. To investigate whether CRT plays a role in the export 
of TRa, a number of different cell lines were transiently transfected with GFP- 
TRa and nucleocytoplasmic shuttling w as m easured through fluorescence 
recovery after photobleaching (FRAP) in multinucleate live cells (monokaryons.) 
Interestingly, transfected HeLa (human) cells treated with LMB showed only slow 
TRa shuttling, a s  opposed to the rapid shuttling observed in fused HeLa/NIH-3T3 
(m ouse) heterokaryons treated with LMB. These results suggest that in live, 
unfused cells, CRM1 may play som e role in the nuclear export of TRa. Mouse 
cells deficient in CRT expression (crt-/-) and their wildtype counterparts (crt+/+) 
were also transiently transfected with GFP-TRa. Consistent with a CRT-mediated 
export pathway, crt-/- monokaryons showed limited nucleocytoplasmic shuttling 
of GFP-TRa, w hereas crt+/+ monokaryons displayed shuttling activity similar to 
that of HeLa cells not treated with LMB. Taken together, these  data point to the 
intriguing possibility that TRa utilizes a cooperative export pathway involving the 
formation of a trimeric export complex in which CRT binds directly to TRa and 
serves a s  an adapter of TRa binding of CRM1.
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NUCLEAR EXPORT OF THE THYROID HORMONE RECEPTOR a
CHAPTER 1: GENERAL INTRODUCTION
The thyroid hormone receptor a l  (TRa) is a member of the nuclear receptor 
superfamily of transcription factors and regulates the expression of thyroid hormone (T3 )
- responsive genes. In conjunction with T3 ,T R a serves as an important modulator of 
critical developmental processes as well as maintenance of homeostasis in vertebrates. 
Like many other nuclear receptors, TR a shuttles between the nucleus and cytoplasm of 
the cell. An important aspect of this nucleocytoplasmic shuttling is the process by which 
TR a is exported from the nucleus through the nuclear pore complex. Recently, a great 
deal of interest has been placed on studying the nuclear export pathways followed by 
nuclear receptors as well as in the consequences associated with aberrant nuclear receptor 
expression and mislocalization. Mutant forms of TR, for example, have been linked to a 
host o f pathological conditions including several types o f cancer and thyroid hormone 
resistance syndrome. Despite this increase in research, however, the export pathway(s) 
followed by many nuclear receptors remain poorly understood. Understanding the precise 
mechanism by which TR a shuttles between the nucleus and cytoplasm will shed light 
into its regulatory functions, as well as serve as a basis for better understanding the 
diseases associated with its misexpression. The primary objective of this thesis was to 
define the nuclear export pathway followed by TRa. The following introduction will 
provide a background in thyroid hormone endocrinology, what is known of T R a 
function, and an overview of nuclear transport in general.
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THYROID HORMONES
Production and regulation o f  thyroid hormone
Thyroid hormone is produced within the thyroid gland through a chemical 
reaction which couples two iodinated tyrosine molecules [Gavaret et ah, 1981]. The 
major product of this reaction, 3,5,3',5'-tetraiodothyronine (T4 ) accounts for the vast 
majority of thyroid hormone produced in the thyroid gland. Thyroid hormones are 
secreted from the gland into circulation, where they complex soluble binding proteins 
such as thyroxine-binding globulin [Burrow, 1993; Seo, 1996], albumin, and transthyretin 
[Schreiber, 2002]. These complexes are then transported throughout the body where 
inactive T4  is converted to an active state at peripheral tissues by deiodinases [Robbins, 
1981; Koenig, 2003]. The product of this deiodination, 3,5,3'-triiodothyronine (T3 ), acts 
locally to maintain homeostasis in accordance with ambient environmental conditions. In 
addition, T 3 activity is crucial to the development and growth of many animal species.
The thyroid gland is one component of an important region known as the 
hypothalamo-pituitary-thyroid axis [Berne and Levy, 1990]. Specifically, the thyroid 
gland acts as both an effector for hormones secreted by the hypothalamus and anterior 
pituitary and also serves as a negative regulator of these structures when sufficient T3 is 
in circulation. The process of thyroid hormone synthesis begins when various metabolic 
signals stimulate the hypothalamus to produce the peptide thyrotropin-releasing hormone 
(TRH). After movement through axons, TRH enters the blood through the portal capillary 
plexus and is subsequently delivered to the pituitary gland where it positively regulates 
the production of thyrotropin (TSH). After exocytosis from thyrotropes within the
3
anterior pituitary, TSH then stimulates the production and secretion of T4  and, to a lesser 
degree, small amounts of T3 from the thyroid gland (Fig. 1).
Physiological effects o f  thyroid hormones
Thyroid hormones play important roles in animal physiology from early 
development onward. In mammals, for example, T3 stimulates maturation of growth-plate 
cartilage [Burch and Lebovitz, 1982; Rabier et al., 2006], regulates neonatal growth 
hormone production [de Picoli Souza et al., 2006], and is involved in both testicular 
sertoli cell [Holsberger et al., 2005; McCoard et al., 2003] and ovarian granulosa cell 
development [Ko et al., 2003]. Most importantly, perhaps, T3 and T4  supplied through the 
placenta have critical effects on the development of the fetal central nervous system and 
maternal hypothyroidism can have detrimental effects on fetal neurodevelopment 
[Morreale de Escobar et al., 2004].
In adults, increased levels of thyroid hormones raise basal metabolism and 
thermogenesis by increasing the rate of O2  consumption [Wrutniak-Cabello et al., 2001; 
Saelim et al., 2004; Chieffi Baccari et al., 2004] and ATP hydrolysis [Arruda et al., 2003; 
Kurihara et al., 1996]. In support o f this increase in respiratory function, thyroid 
hormones also increase the rate o f ventilation [Berne and Levy, 1990] and red blood cell 
mass through the upregulation of erythropoietin [Dainiak et al., 1986]. These and many 
other important metabolic pathways are mediated through thyroid hormone interaction 
with their cellular receptors, known collectively as thyroid hormone receptors (TRs).
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Figure 1 -  Regulation of thyroid hormone production. Thyroid hormone synthesis is 
regulated through a negative feedback mechanism involving the hypothalamus and 
pituitary gland. After local conversion from the abundant T4  thyroid hormone to the more 
active T3 form, circulating T3 inhibits the production of both thyrotropin-releasing 
hormone from the hypothalamus and thyroid stimulating hormone from the anterior 
pituitary. In contrast, low levels o f T3 allow the production of TRH and TSH to positively 
regulate T4  and T3 production.
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THYROID HORMONE RECEPTORS
Thyroid hormone receptor structure
The two major forms of TR, TR a and TR/3, are encoded on human chromosomes 
17 and 3, respectively [Lazar, 1993]. TR/3 exists in two major isoforms which are 
generated through multiple promoter usage [Wood et al., 1996]. Both of these proteins, 
termed TR/3-1 and TR/3-2, are capable of binding T3 as well as regulatory elements within 
target DNA promoters called thyroid hormone responsive elements (TREs). Like TR/3, 
TR a also exists in several isoforms. The major isoforms of TRa, however, arise through 
alternative splicing o f a
common mRNA transcript under the control of a single promoter rather than multiple 
promoter useage [Izumo and Mahdavi, 1988]. While TRa-1 (hereafter referred to as TRa) 
is similarly capable of binding T3 and TREs, TRa-2 contains an amino acid substitution 
within the carboxy terminus which prevents T3 binding and allows only weak TRE 
association [Lazar et al., 1989].
The major TR isoforms share several common structural characteristics which, as 
is the case for other members of the nuclear receptor superfamily, are central to their 
function in gene regulation. These highly conserved domains consist of an amino- 
terminal transactivation domain (A/B domain), the DNA-binding domain (C domain), a 
small hinge region (D domain), and the carboxy-terminal ligand-binding domain (E 
domain) (Fig. 2a) [Shank and Paschal, 2005]. In addition to their nominal function, these 
regions also serve as important staging areas for a multitude of positive and negative 
regulatory factors as well as the basal transcription machinery.
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Figure 2 -  Structure of thyroid hormone receptors. A, TR exists in several major 
isoforms. TR a and TRp are produced through alternative splicing and alternative 
promoter useage, respectively. All receptor isoforms share similar domain structure 
including an amino terminal transactivation (A/B) domain, DNA binding domain (DBD), 
hinge region, and carboxy terminal ligand binding domain (LBD) but differ slightly in 
specific amino acid composition. B, The DBD of TR isoforms is highly conserved. This 
region consists o f two zinc finger motifs and an interspersed DNA recognition helix. 
Phenylalanine residues (F) believed to be important in the nuclear export o f TR are 
highlighted in red [adapted from Rastinejad et al., 1995].
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The amino acid motif through which TRs come into contact with TREs is the 
DNA binding domain (DBD). The DBDs of TRa, TR/3 and other members of the nuclear 
receptor superfamily are formed by two zinc finger motifs connected by a short DNA 
recognition helix [Rastinejad, 1995; Shank and Paschal, 2005]. Several amino acids 
within a highly conserved region of the upstream zinc finger known as the P-box directly 
interact with phosphate groups and nucleic acids within the major groove of target TREs 
to promote TR binding [Nelson et al., 1995]. In addition, numerous amino acids 
throughout the DBD serve as the interfaces for TR binding of the retinoid X receptor 
(RXR), a related nuclear receptor which serves as a common dimerization partner o f TR 
[Rastinejad et al., 1995] (Fig. 2b). Although TR:TR homodimers and TR monomers are 
capable o f binding TREs, much of TR binding is thought to occur through this TR:RXR 
heterodimerization.
Another highly conserved region of TR is the ligand-binding domain (LBD). This 
is where T3 binds and also plays a part in TR homodimerization [Lee et al., 1992], 
heterodimerization [Kakizawa et al., 1997] and transcriptional activation [Baniahmad et 
al., 1995]. Similar to other nuclear receptors, the LBD of TR contains a hydrophobic 
pocket formed by discontinuous stretches o f amino acids spanning its length. Upon T 3 
binding a conformational shift occurs which buries the hormone deep within the 
hydrophobic helices which compose this pocket [Wagner et al., 1995].
Between the TR DBD and LBD lies a hinge region which is highly conserved 
between different TR isoforms, as well as with other nuclear receptor [Yen, 2001]. The 
hinge region of nuclear receptors generally contains a lysine-rich region which extends 
N-terminally into the DBD. This sequence, termed a nuclear localization sequence
(NLS), is responsible for nuclear receptor binding of transport proteins involved in 
nuclear import and bears sequence homology to the well characterized simian virus 40 T 
antigen NLS [LaCasse et al., 1993; Hodel et al., 2001]. In addition to its role in nuclear 
localization and conferring conformational shifts within the protein, the hinge region also 
is likely to be involved in binding of transcriptional coregulators [Chen and Evans, 1995; 
Horlein et al., 1995; Reutrakul et al., 2000].
The most variable region between TR isoforms is the amino-terminal 
transactivation (A/B) domain. While the role of the A/B domain between different TR 
isoforms and other NRs is still an active area of investigation, there is recent evidence 
which points to a role for this region in both the direct binding of coregulators [Iwasaki et 
al., 2006] as well as the recruitment of coregulators to other TR domains [Tian et al., 
2006]. The substantial variation in A/B domain sequence and corresponding differences 
in coregulator recruitment suggests that this region may be important in regulating 
transcription based on cell-type or environmental conditions.
All o f these structural features play a significant role in the interaction of TR with 
a host of regulatory proteins. Through recruitment of coactivators and corepressors, TRs 
positively or negatively regulate target genes in a ligand-dependent manner.
Thyroid hormone receptor regulatory activity
Unlike many nuclear receptors, TRs are capable o f binding to their responsive 
elements in either the presence or absence of ligand [Lazar, 1993; Evans, 1988]. Under 
most circumstances, TR binds TRE half-sites as a heterodimer with RXR and recruits 
coregulatory proteins in a ligand-dependent manner. Most TR binding occurs at positive-
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TREs. Under these circumstances, the absence of T3 allows corepressor proteins to 
associate with TR [Sanchez-Pacheco and Aranda, 2003]. In the case of both TR a and 
TR/3 these corepressors inhibit the formation of the basal transcriptional machinery 
preinitiation complex by interacting directly with transcription factor IIB-TATA binding 
protein (TFIIB) complex, an intermediate in the formation of the preinitiation complex 
[Fondell et al., 1996; Tong et al., 1995].
Two of the most extensively studied corepressors with which TR associates are 
the nuclear receptor corepressor (NCoR) and the silencing mediator of retinoid and 
thyroid hormone receptors (SMRT) (Fig. 3a). The precise mode of transcriptional 
repression brought about through these interactions remains an active area of research. 
There have, however, been a number of models put forth attempting to explain this 
repression. For example, although NCoR and SMRT lack intrinsic deacetylation 
domains, they have been shown to recruit additional proteins including Sin3, which 
modulates transcriptional activity by interacting with DNA-binding proteins [Wang and 
Stillman, 1993]. In addition, histone deacetylases (HDACs) also account for much of this 
repressional activity [Heinzel et al., 1997; Nagy et al., 1997]. HDACs remove negatively 
charged acetyl groups from lysine residues found within the N-terminal tails o f histones 
which, when present, prevent the negatively charged DNA from associating with these 
proteins. Removal of acetyl groups therefore allows DNA to wrap more tightly around 
the histone core octamer and prevents the binding o f coactivators. While NCoR and 
SMRT are not recruited exclusively by TR, there have been a number o f specific TR 
regulated target genes identified which are known to be dependent on their expression. In 
liver hepatocytes, for example, genes for expression of Spot 14, glucose 6 -phosphate, and
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Figure 3 -  Negative and positive regulation of T3-responsive genes mediated through 
TR activity. A, Inhibition o f T3 -responsive genes occurs in the absence o f T3 . 
Recruitment o f corepressors including NCoR, SMRT and histone deacetylase (HDAC) to 
TR:RXR heterodimers maintains tight chromatin coiling around histones and prevents 
efficient association of the transcriptional machinery with promoter regions. B,
Activation of T3 -responsive genes occurs when T3 is at high levels. T3 binding allows 
recruitment of coactivators including SRCs and histone acetyl transferase (HAT) to 
TR:RXR heterodimers bound to TREs within promoter regions. Coactivator recruitment 
promotes association o f the transcriptional machinery with promoter regions of T 3 -  
responsive genes.
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5’-deiodinase were increased when these corepressors were inhibited [Feng et al., 2001]. 
More recently, a TR:NCoR interaction was also shown to be involved in the regulation of 
the cellular matrix protein CD44 and may have implications towards the onset of 
papillary thyroid carcinomas [Kim et al., 2005].
In contrast to unliganded TR, liganded TR associates preferably with coactivator 
proteins. Upon T3 binding, TR undergoes a conformational shift which exposes binding 
sites for interaction with coactivator proteins including members o f the p i 60 family 
called steroid receptor coactivators (SRCs) [Moore and Guy, 2005]. Ligand-dependent 
SRC recruitment and recruitment of associated coactivators promotes the assembly of the 
preinitiation complex at promoter regions. Specifically, T3 binding of TR increases the 
affinity o f TFIIB, TATA-binding protein, and Cdk7 for the promoters of T3 -responsive 
genes. Similarly to corepressors, coactivators also recruit other regulatory proteins to 
TREs (Fig. 3b). In contrast to corepressors, however, coactivators often possess intrinsic 
acetylation activity or associate with histone acetyl transferases (HATs). Acetylation of 
histone N-terminal tails loosens the association of DNA with the histone core octamer 
and allows more efficient transcription of genes in the acetylated regions. In addition, 
some HATs such as p300 and CREB binding protein (CBP) form direct complexes 
between nuclear receptors and the transcriptional machinery [Kalkhoven 2004]. 
Coactivators are involved in a number of coregulatory roles in thyroid hormone 
signaling. For example, mice deficient in several SRC proteins display a range o f 
conditions including resistance to thyroid hormone syndrome, altered regulation of TSH 
production, and various effects in liver and heart tissue [Gauthier et al., 1999; Sadow et 
al., 2003a; Sadow et al., 2003b; Sadow et al., 2003c].
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NUCLEOCYTOPLASMIC TRANSPORT
The nuclear pore complex
Like other transcription factors which bind to DNA regulatory elements, TRs 
must first gain access to the nucleus by traversing the nuclear envelope. The channels 
through which proteins, RNA and ribonucleoproteins (RNPs) cross this barrier are called 
nuclear pore complexes (NPCs). These large structures o f -  125 MDa serve as the sole 
crossing point for macromolecules greater than -  40 kDa in size and also accommodate 
the diffusion of smaller molecules and ions. Unlike the transport of proteins and RNPs 
across the membranes surrounding other compartments such as the endoplasmic 
reticulum or mitochondria, nuclear transport through the NPC is fundamentally different 
in that large protein assemblies cross completely folded into their native structure 
[Gorlich and Kutay, 1999]. Indeed, transport of particles as large as ribosomal subunits 
through the NPC occurs frequently [Daneholt, 1997].
The number of NPCs within a given cell varies depending on its particular 
metabolic and transcriptional needs. In proliferating human cells, for example, anywhere 
from 3,000 to 5,000 NPCs per nucleus have been found [Rout and Blobel, 1993]. In
n
contrast, a mature Xenopus laevis oocyte may have on the order of 10 NPCs [Cordes et 
al., 1995]. Although the relative number of NPCs differs considerably across cell type 
and species, the specific structure of the NPC is highly conserved and reflects the 
importance of the nuclear transport process for eukaryotes in general.
The NPC exhibits 8-fold symmetry and consists of several regions which are 
composed of -  30 different proteins called nucleoporins [Fahrenkrog et al., 2004].
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Together, these proteins form the structures that span the diameter of the nuclear 
envelope and extend into both the cytosol and nucleus. In addition to their role in directly 
interacting with cargoes, nucleoporins also associate in complexes which are essential to 
the formation of the completed NPC. In humans, for example, particles composed of nine 
different nucleoporins called Nupl07-160 complexes are found on either side of the 
central framework [Krull et al., 2004]. Removal of these complexes resulted in nuclei 
devoid of NPCs, demonstrating the importance of nucleoporin interaction to NPC 
formation in vivo [Walther et al., 2003a].
The aqueous channel which the NPC forms reaches its narrowest point in the 
membrane spanning portion of the central framework. At this point, the channel spans a 
diameter of roughly 50 nm and, accordingly, accommodates the transport o f cargoes 
which are slightly smaller [Pante and Kann, 2002]. When visualized by electron 
microscopy or other imaging techniques, this central pore often appears to be obstructed 
by a “plug”, the origin o f which has remained controversial [Stoffler et al., 2003; Danker 
and Oberleithner, 2000]. Some studies have provided evidence for the assertion that this 
is actually cargo which is in the process o f crossing compartments [Stoffler et al., 2003; 
Beck et al., 2004]. Alternatively, this obstruction may be a component o f the NPC itself. 
Recent work has suggested that the phenylalanine-glycine (FG) repeats found within 
nucleoporins form a meshwork through which shuttling proteins must pass [Frey et al., 
2006; Frey and Gorlich, 2007]. This meshwork, termed a “hydrogel”, may appear as a 
distinct object within the central pore when viewed through microscopy.
In addition to the central framework, the NPC is also composed of peripheral 
structures including the nuclear basket and cytoplasmic filaments. Like the central
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framework, these regions are also made up of nucleoporins. It is at these points that many 
transport factors transiently associate with the FG repeats and promote the binding of 
import and export chaperones to the NPC [Gorlich and Kutay, 1999].
The nuclear import cycle
Structures greater than ~ 40 kDa in size cannot diffuse through the NPC. It is only 
through association with soluble transport factors termed karyopherins that these large 
particles can enter or exit the nucleus. Karyopherins interact with a number of other 
factors both in the cytosol and nucleus to facilitate the assembly, translocation, and 
disassembly of transport complexes. While both nuclear import and export remain active 
areas o f research, the nuclear import cycle has been more extensively studied and is 
currently better understood than the nuclear export cycle.
Proteins which contain a basic nuclear localization sequence (NLS) generally 
access the nucleus through importin a/$ recognition [Fried and Kutay, 2003; Pemberton 
and Paschal 2005; Cook et al., 2007]. There are some NLS substrates which im porting 
can bind directly. Most cargoes, however, require one of a suite of importin-o; family 
members to serve as an adapter for recognition of importin-/3. Importin-a has several 
structural characteristics which allow it to act as an ideal binding partner for both NLS 
bearing substrates and importin-/3. In the case o f NLS cargo binding, specific acidic 
residues which line the inner concave surface o f importin-of make direct contact with the 
side chains of basic amino acids which comprise the classic NLS [Conti et al., 1998; 
Fontes et al., 2000]. This importin-a:NLS complex can then bind importin-/3 directly
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through the im porting binding (IBB) domain of importin-o; thereby forming the import 
complex [Kobe, 1999].
The precise mechanism by which material crosses the NPC has remained 
controversial. It is well known, however, that FG-repeats found within nucleoporins play 
a significant role in allowing both transport of some substrates [Bayliss et al., 2002a; 
Bayliss et al., 2002b] and excluding the transport of others [Ribbeck and Gorlich, 2002]. 
In the case of nuclear import, the hydrophobic phenylalanine side chains found within the 
FG-repeats of nucleoporins bind to shallow hydrophobic cavities on the surface of 
transport proteins such as importin-a; and importin-/3 [Stewart, 2007; Bayliss et al., 1999]. 
Although strong enough to permit association with the NPC, these hydrophobic 
interactions are also weak enough to prevent prolonged binding of the transport 
machinery to the NPC which would inhibit rapid shuttling o f cargo substrates [Bayliss et 
al., 1999].
After crossing from the cytosol to the nucleus via the NPC, the import complex 
encounters the GTPase Ran (Fig. 4). Although bound to GTP within the nucleus, Ran can 
also be found in a GDP bound state in the cytosol. The GTPase cycle occurrs through 
regulation by a number o f associated proteins and is critical for nuclear transport 
[Pemberton and Paschal, 2005]. Indeed, maintenance o f the differential gradient o f 
RanGDP and RanGTP found between these compartments is the primary mechanism by 
which directionality o f cargo transport is established. RanGTP binds directly to importin- 
(3 in the nucleus, thereby inducing a conformational shift which releases the IBB domain 
o f importin-a from the RanGTP :importin-/3 complex through an allosteric mechanism 
[Lee et al., 2005]. Interestingly, the importin-o; IBB domain possesses sequence
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homology to the basic NLS found in many cargoes and, therefore, self-competes with 
cargo for the NLS binding site within importin-o: in the absence of importin-/? [Kobe et 
al., 1999]. This competition facilitates the release of cargo from importin-a within the 
nucleus.
Once cargo has been delivered to the nucleus, importins a/ a r e  recycled through 
the NPC back into the cytosol where they are free to participate in another round of 
nuclear import [Pemberton and Paschal, 2005; Stewart, 2007; Fahrenkrog and Aebi,
2003]. Importin-/? translocates through the NPC bound to RanGTP. After GTP hydrolysis 
in the cytosol aided by the cofactor Ran GTPase activating protein (RanGAP), the 
importin-/3:RanGDP complex dissociates and importin-/? is free to associate with another 
import complex (Fig. 4). RanGDP is subsequently recycled back to the nucleus in 
association with nuclear transport factor-2 (NTF2). In the nucleus, chromatin-bound Ran 
guanine nucleotide-exchange factor (RanGEF) facilitates the replacement of GDP with 
GTP, thereby reestablishing the RanGTP gradient [Pemberton and Paschal, 2005; Cook 
et al., 2007].
Recycling o f importin-a occurs in a similar fashion, although this requires 
recognition by RanGTP bound CAS (cellular apoptosis susceptibility protein) [Kutay et 
al., 1997, Gorlich 1998]. The CAS:RanGTP complex mediates the export of importin-a 
to the cytosol. Following export, RanGAP mediated RanGTP hydrolysis facilitates the 
dissociation o f this complex and release o f importin-a. Although CAS does not appear to 
recognize any cargoes in addition to importin-a, this chaperone is nevertheless critical for 
the survival o f organisms as it allows continuous import to proceed [Pemberton and 
Paschal, 2005].
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The nuclear export cycle
In addition to the recycling of importins from the nucleus back to the cytosol, the 
distribution of RNA, shuttling transcription factors, and RNPs is also continuously 
regulated through nucleocytoplsmic shuttling. The significance of nucleocytoplasmic 
shuttling to gene regulation remains a major area of research. Sequestering nuclear 
receptors and other shuttling proteins in the cytosol presumably influences transcription 
on a number of levels. Nuclear export could, for example, serve as a means of attenuating 
transcription levels in response to hormones and other signaling molecules [Shank and 
Paschal, 2005; Tyagi et al., 2000] and may target particular proteins for ubiquitin- 
mediated proteasome degradation [Nawaz et al., 1999]. Alternatively, transcription 
factors including nuclear receptors may influence gene expression through interaction 
with a number of signaling cascades in the cytosol [Bonamy and Allison, 2006; Lu et al.,
2002]. These non-genomic functions are currently not well understood but will 
undoubtedly be important to the future study of a multitude o f disease pathways.
The pathways which proteins utilize to exit the nucleus remain to be precisely 
defined. There are, however, several general similarities observed between the import 
cycle and what is known of nuclear export. Like nuclear import, this process requires 
recognition by protein chaperones which facilitate movement through the NPC. Export 
receptors have been identified for substrates including mRNA [Lei and Silver, 2002], 
microRNA [Kim, 2004; Zeng and Cullen 2004] and tRNA [Kutay et al., 1998]. In the
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Figure 4 -  Nucleocytoplasmic shuttling of proteins across the nuclear envelope. A,
Nuclear localization sequence (NLS) bearing substrates are recognized in the cytosol by 
transport proteins termed importins. Following importin-mediated translocation through 
the nuclear pore complex (NPC), RanGTP in the nucleus binds importin and causes the 
disassociation of the import complex. Subsequently, importins are recycled back to the 
cytosol and released through the hydrolysis of RanGTP to RanGDP. B, Nuclear export 
sequence (NES) bearing substrates are recognized by complexes composed of RanGTP 
and export receptors termed exportins. The export complex translocates through the NPC 
and dissociates in the cytoplasm after GTP hydrolysis o f RanGTP to RanGDP.
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case of protein shuttling, the best characterized nuclear export pathway involves 
recognition by the karyopherin CRM1 of the hydrophobic NES, a loosely conserved 
motif which generally contains several leucine residues [Pemberton and Paschal, 2005]. 
All eukaryotes appear to utilize the CRM 1-mediated nuclear export pathway, and over 75 
proteins have been identified which contain a hydrophobic NES [Pemberton and Paschal, 
2005; la Cour et al., 2003].
CRMl-mediated nuclear export
CRM 1 mediates the export o f many substrates through recognition of the 
hydrophobic NES. Major classes of export substrates which are recognized through 
CRM 1 binding include transcription factors, cell cycle regulators and RNA binding 
proteins [Fried and Kutay, 2003]. Like other exportins including CAS, CRM1 requires 
RanGTP binding within the nucleus for efficient nuclear export. Although capable of 
binding NES lacking adapter molecules such as snurportin with relatively high affinity 
[Paraskeva et ah, 1999], CRM1 binding to NES-containing substrates is relatively weak 
[Kutay and Guttinger, 2005]. This weak interaction may, in fact, be critical to the nuclear 
export of NES substrates via CRM1. Indeed, unusually strong NES sequences selected 
from a peptide library bind to CRM1 with much higher affinity and cause the 
accumulation of these complexes at the cytoplasmic face of the NPC [Engelsma et ah,
2004].
Although additional export inhibitors have recently been identified [Meissner et 
ah, 2004], the most effective and widely used approach to studying CRMl-mediated 
nuclear export has been the employment of leptomycin B (LMB) in nucleocytoplasmic
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shuttling assays. LMB is an unsaturated, branched-chain fatty acid which serves as an 
anti-fungal agent for Streptomyces bacteria and also acts as a potent inhibitor of CRM1 
function [Kumar et al., 2006; W olff et al., 1997]. Specifically, the direct interaction 
between CRM1 and the NES of export cargo is disrupted through covalent modification 
of a critical cysteine residue at position 529 of CRM1 [Kudo et al., 1999]. Inhibition of 
CRM 1 effectively sequesters proteins which shuttle between the nucleus and cytoplasm 
in the nuclear compartment.
Nuclear receptors have been extensively investigated for the presence of a classic 
hydrophobic NES. To date, however, no such sequence has been identified [Shank and 
Paschal, 2005]. Despite this apparent lack in CRM 1-dependence, the possibility remains 
that a NES resembling the classic leucine-rich sequence may appear in some nuclear 
receptors as a result of protein folding and the resulting tertiary structure. Alternatively, 
CRM 1 sometimes binds adapter proteins which serve as a bridge for the binding of other 
export cargoes [Lindsay et al., 2001; Englmeier et al., 2001].
Although nuclear receptors lack the consensus NES associated with CRM l- 
mediated export, there has nevertheless been a substantial amount of controversy over the 
role o f this exportin in their nuclear export. For example, while nuclear export of the 
glucocorticoid receptor (GR) [Tyagi et al., 2000; Liu and DeFranco 2000], thyroid 
hormone receptor (TR) [Bunn et al., 2001] and progesterone receptor (PR) [Tyagi et al.,
1998] appear to be insensitive to LMB treatment under certain conditions, other 
experiments have demonstrated at least a partial inhibition of CRM 1 -mediated nuclear 
receptor export in the presence of LMB [Savory et al., 1999; Itoh et al., 2002; present 
study]. These discrepancies highlight the complexity of the export process and point to
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the possibility of multiple nuclear export pathways. O f particular interest, the Ca - 
binding protein calreticulin has been identified as a potential additional exportin for the 
export o f nuclear receptors.
Calreticulin
2_j_
Calreticulin (CRT) was originally identified as Ca -binding protein in the 
sarcoplasmic reticulum [Ostwald and MacLennan, 1974] and, subsequently, was 
identified as a major protein component found within the endoplasmic reticulum 
[Michalak et al., 1992]. Structural analyses have indicated that CRT contains three 
distinct regions. The amino-terminal N-domain consists of a segment which, among other 
functions, serves as the binding site for members of the nuclear receptor family 
[Coppolino and Dedhar, 1998]. In addition, CRT is composed of a P-domain which 
contains a high-affinity, low capacity Ca2+-binding site and a carboxy-terminal C-domain 
which is the site of a number of post-translational modifications and has been proposed to 
function in the nuclear import of the protein [Coppolino and Dedhar, 1998].
Consistent with its structural features, CRT serves many biological functions and 
is essential for development. Indeed, although CRT-deficient cell lines can be kept in 
culture, CRT-deficient mice are embryonic lethal at 14.5-16.5 days development 
[Mesaeli et al., 1999]. In addition to its well characterized role in the maturation of newly 
synthesized proteins within the ER [Hebert et al., 1997] and in Ca2+homeostasis [Krause 
and Michalak, 1997; Holaska et al., 2002], CRT also participates in a multitude of other 
cellular processes including the downregulation of nuclear receptor regulated gene 
expression [Dedhar et al., 1994; Bums et al., 1994] and the nuclear export of nuclear
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receptors [Holaska et al., 2001]. Previously, the mechanism by which CRT comes into 
contact with nuclear receptors was an unresolved question. However, recent reports have 
identified small but distinct populations of CRT within the cytosol and nuclei of various 
cell types [Sharma et al., 2004; Kobayashi et al., 2006; present study]. In addition, a 
previously unknown pathway for CRT retrotranslocation from the ER to the cytoplasm 
has been described which may provide a means by which CRT accesses the nucleus 
[Afshar et al., 2005].
Calreticulin-mediated export o f  GR and interaction with nuclear receptors
Through a combination of approaches including transfection assays and 
permeabilized cell nuclear export assays GR was found to utilize CRT as an export 
receptor [Holaska et al., 2001]. Contrary to CRMl-mediated recognition of the leucine 
rich NES, CRT mediates GR nuclear export through recognition of the GR DBD 
[Holaska et al., 2001]. Interestingly, subsequent studies found that the DBD of nine other 
steroid, nonsteroid (including TR/3), and orphan nuclear receptors also mediated CRT- 
dependent nuclear export. This interaction occurs through the fifteen amino acid 
sequence between the zinc finger domains of the DBD (Fig. 2b) and is most sensitive to 
mutation o f two phenylalanine residues found in the upstream portion o f this region 
[Black et al., 2001].
Perhaps the most convincing support for CRT-dependent nuclear export o f GR is 
the observation that mouse embryonic fibroblasts deficient in CRT expression (crt-/- 
cells) fail to support translocation o f recombinant GR-green fluorescent protein (GFP) 
from the nucleus to the cytoplasm [Holaska et al., 2001]. In these experiments, GR was
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induced by dexamethasone treatment to localize to the nucleus. In crt-/- cells, removal of 
this glucocorticoid analogue did not induce a shift in GR localization to the cytoplasm 
after several hours. However, transfection of recombinant CRT to the same cells restored 
GR export. Parallel experiments with control embryonic fibroblasts (crt+/+ cells) also 
supported nuclear export of transfected GR [Holaska et al., 2001].
Although there are several compelling lines of evidence for the CRT-mediated 
nuclear export of GR, there has also been evidence which suggests that CRT-mediated 
nuclear export may be a specific stress response to environmental conditions brought 
about by a particular experimental technique [Walther et al., 2003b]. This method, called 
a heterokaryon assay, has been used extensively in the study of nuclear receptor 
trafficking [Bunn et al., 2001; Chandran and DeFranco, 1992; Black et al., 2001; Madan 
and DeFranco 1993; Maruvada et al., 2003; Hache et al., 1999; DeLong et al., 2004] but, 
in light of recent reports, its validity to normal cellular physiology has been questioned.
The heterokaryon assay
Heterokaryon assays are useful in the study o f nuclear transport because they 
allow the visualization of both nuclear export and nuclear import, or the absence of either 
process. In addition, this assay is particularly helpful in the study of proteins which 
appear at steady state to be localized to a single compartment but actually exhibit rapid 
nucleocytoplasmic shuttling [Bunn et al., 2001].
In heterokaryon formation, one particular population of cells (e.g. mouse) 
contains an endogenous protein of interest or has been transiently transfected with the 
expression plasmid for a particular protein. Subsequently, another population of cells
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(e.g. human) lacking this same protein is co-plated and the cytoplasms of the two 
populations are fused through exposure to 50% polyethylene glycol (PEG) (Fig. 5). The 
protein of interest can then be monitored for nucleocytoplasmic shuttling. Localization to 
acceptor nuclei (e.g. human) is thus indicative of both nuclear export and subsequent 
reimport.
PEG-induced cytoplasmic fusion disrupts the integrity of the ER, thereby 
resulting in a transient increase in free cytosolic CRT [Walther et al., 2003b]. It has been 
postulated, therefore, that the rapid, CRT-mediated nucleocytplasmic shuttling of GR and 
other nuclear receptors [Black et al., 2001] is a specific and temporary response to this 
cellular stress. These observations, combined with the knowledge that GR shuttles only 
slowly in a CRT-independent manner in unfused cells [Walther et al., 2003b], have led to 
the conclusion that the heterokaryon assay may be an inadequate stand-alone technique 
for the study of nuclear transport. For this reason, other methods in addition to 
heterokaryon assays including in vivo cellular imaging and fluorescence recovery after 
photobleaching have recently been employed in the study of nucleocytoplasmic shuttling.
In vivo fluorescence recovery after photobleaching (FRAP)
The development and manipulation of fluorescent markers as protein tags has 
greatly increased the efficiency with which numerous subcellular molecular processes 
can be monitored [Lippincott-Schwartz and Patterson, 2003]. In particular, GFP isolated 
from the jellyfish Aequorea victoria and its variants have been particularly useful 
markers in recent years. Concurrent with the development of fluorescent protein 
technology, a number o f powerful microscopic techniques have recently also seen vast
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Figure 5 -  Polyethylene glycol (PEG)-induced heterokaryon formation. One
population of cells (i.e. mouse) is transfected with the DNA encoding a protein of 
interest. Subsequently, a second population (i.e. human) o f cells is co-plated. Following 
PEG-induced cytoplasmic fusion, the protein o f interest can be monitored for movement 
from donor nuclei to acceptor nuclei. This movement represents nuclear export from 
donor nuclei and nuclear import into acceptor nuclei.
improvements [Koster et al., 2005]. Among these is fluorescence recovery after 
photobleaching (FRAP).
FRAP utilizes an appropriate laser line in concert with high resolution microscopy 
to take advantage of the fluorescence properties of particular fluorophores. During FRAP 
experiments a population of fluorophores is exposed either repeatedly to low laser 
intensity or briefly to higher intensity laser illumination with the effect that the 
fluorophore is covalently modified, rendering it unable to emit fluorescence [Lippincott- 
Scwhartz et al., 2001]. Although this loss of fluorescence intensity, or photobleaching, is 
often an undesirable consequence o f fluorescence microscopy, it can also be used 
advantageously to examine the movement o f unbleached molecules from neighboring 
areas into a designated bleached region (Fig. 6 ). In the context o f nucleocytoplasmic 
shuttling, assays have been developed in which cells of one particular cell type that 
naturally contain multiple nuclei (monokaryons) are transfected with a fluorescently 
labeled protein and bleached appropriately to monitor protein movement [Howell and 
Truant, 2002]. In contrast to heterokaryon assays, shuttling assays in a monokaryon 
system offer the distinct advantage that little cellular manipulation is required prior to 
observing protein movement. Presumably, therefore, cellular signaling and transport 
pathways which may be compromised or altered during PEG-induced cell fusion remain 
intact.
Questions addressed in thesis manuscript
The specific nuclear export pathways which nuclear receptors utilize for 
nucleocytoplasmic shuttling have remained elusive. Recently, there has been evidence
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FIGURE 6 -  Fluorescence recovery after photobleaching (FRAP). A, A region of 
interest (ROI) is selected in which a population of fluorophores is bleached with an 
appropriate laser line (red square). Following photobleaching, fluorophores are monitored 
over a timecourse for movement from an unbleached ROI (blue circle) into the 
photobleached region. B, Graphical representation of fluorescence recovery after 
photobleaching. After a period of time, fluorescence intensity between bleached and 
unbleached regions will equilibrate. This equilibration represents the movement of 
fluorophores from an unbleached region (blue curve representative o f blue circle in A) to 
bleached region (red curve representative of red square in A).
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both for [Holaska et al., 2001; Black et al., 2001; Holaska et al., 2002] and against 
[Walther et al., 2003b] a role for CRT in the export of the glucocorticoid receptor and 
other nuclear receptor proteins. The fact that TR a shares a high degree o f sequence 
homology and functional activity with these nuclear receptors leads to the question of 
whether TRo: might utilize a similar export pathway. This, coupled with the knowledge 
that PEG-induced cytoplasmic fusion induces a transient elevation in free CRT levels, led 
to the investigation of TR a shuttling in an in vivo monokaryon system in addition to in 
vitro techniques. The overall objective of this research was to provide insight into the 
relationship o f TR a with the nuclear export machinery, in particular CRM 1 and CRT, and 
to elucidate the mechanism by which TR a exits the nucleus. Understanding the 
mechanism by which TRo: shuttles to the cytoplasm will provide valuable clues as to its 
regulation of T3 -responsive genes, its interaction with oncogenic TR variants, and 
possibly shed light into the export pathways which other nuclear receptors follow. To this 
end, several primary questions were addressed in this research and in the following 
manuscript.
1) Does TR a exhibit rapid nucleocytoplasmic shuttling under unstressed, 
physiological conditions?
2) Is TR a nucleocytoplasmic shuttling sensitive to leptomycin B treatment under 
physiological conditions?
3) Is TR a nucleocytoplasmic shuttling wholly or partially dependent on CRT?
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ABSTRACT
The thyroid hormone receptor a  (TRo;) exhibits a dual role as an activator or 
repressor of its target genes in response to thyroid hormone (T3 .) Previously, we have 
shown that TRo;, formerly thought to reside solely in the nucleus bound to DNA, actually 
shuttles rapidly between the nucleus and cytoplasm. An important aspect of the shuttling 
activity of TRo: is its ability to exit the nucleus through the nuclear pore complex. TRo: 
export is not sensitive to treatment with the CRM 1-specific inhibitor leptomycin B 
(LMB) in heterokaryon assays, suggesting a role for an export receptor other than CRM 1. 
Here, we have used a combined approach o f in vivo fluorescence recovery after 
photobleaching (FRAP) experiments and in vitro permeabilized cell nuclear export assays 
to investigate the export pathway utilized by T R a  We show that, in addition to shuttling 
in heterokaryons, TR a shuttles rapidly in an unfused monokaryon system as well. 
Furthermore, our data point to the intriguing possibility that TR a utilizes a cooperative 
export pathway in which binding of calreticulin (CRT) to both TR a and CRM1 facilitates 
efficient translocation of this trimeric export complex from the nucleus to cytoplasm. 
ABBREVIATIONS
The abbreviations used are: TRa, thyroid hormone receptor a ; TR/3, thyroid hormone 
receptor /3; LMB, leptomycin B; FRAP, fluorescence recovery after photobleaching;
CRT, calreticulin; NLS, nuclear localization signal; NES, nuclear export signal; NPC, 
nuclear pore complex; GR, glucocorticoid receptor; DBD, DNA binding domain; ER, 
endoplasmic reticulum; PEG, polyethylene glycol; GST, glutathione ^-transferase; GFP, 
green fluorescent protein; SV40, Simian virus 40; CMV, cytomegalovirus; DAPI, 4 ’6- 
diamidino-2-phenylindole; DIC, differential interference contrast; RRL, rabbit
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reticulocyte lysate; PKI, protein kinase inhibitor; SRC-1, steroid receptor coactivator-1; 
RanBP3, Ran-binding protein 3; C, cytoplasmic; N, nuclear; MM, magic marker. 
INTRODUCTION
The thyroid hormone receptor a l (TRo;) is a member o f the nuclear receptor 
superfamily of transcription factors. TR a acts as an intracellular receptor for thyroid 
hormone (T3 ), thereby regulating expression of T3 -responsive genes associated with 
many aspects of development, growth, and metabolism. Among the nuclear receptors, 
TR a is particularly intriguing in that it can modulate transcription whether or not it is 
bound to T3 . Consistent with this dual role as an activator or repressor o f transcription, at 
steady state TR a appears to be almost exclusively localized in the nucleus. However, we 
have shown that the receptor, in fact, shuttles rapidly between the nucleus and cytoplasm 
[Bunn et al., 2001]. While the significance of this nucleocytoplasmic shuttling remains to 
be precisely characterized, this activity may be related directly to regulation o f TRa 
target genes as well as to yet unknown non-genomic functions [Bonamy and Allison, 
2006].
Nucleocytoplasmic shuttling occurs as a result of a dynamic balance between the 
recognition of nuclear localization signals (NLS) and nuclear export signals (NES) by 
particular import and export factors termed importins and exportins, respectively [Cook 
et al., 2007]. Most nuclear receptors appear to enter the nucleus via importin a/13 
recognition and subsequent translocation through the nuclear pore complex (NPC) 
[Pemberton and Paschal, 2005; Cook et al., 2007]. Unlike nuclear import, however, the 
export pathways utilized by nuclear receptors remain more elusive.
34
The most thoroughly studied and well characterized nuclear export pathway 
involves the exportin CRM 1. Many shuttling transcription factors outside o f the nuclear 
receptor superfamily utilize a CRM 1-dependent mechanism [la Cour et al., 2003; la Cour 
et al., 2004]. Like other nuclear receptors, however, TRa lacks the leucine-rich NES 
associated with classical CRMl-mediated nuclear export [Bunn et al., 2001; Shank and 
Paschal, 2005]. Concordantly, we have shown through interspecies heterokaryon assays 
that TR a nuclear export is not inhibited by leptomycin B (LMB), a potent inhibitor of 
CRM1 activity. These data clearly indicate that, at least in a heterokaryon system, TR a is 
capable o f utilizing a CRM 1-independent nuclear export pathway [Bunn et al., 2001].
There is compelling evidence which suggests that the Ca2+ binding protein 
calreticulin (CRT) may play a role in the nuclear export of several nuclear receptors 
[Bums et al., 1994; Dedhar et al., 1994; Holaska et al., 1998; Holaska et al., 2001; Black 
et al., 2001]. For example, the glucocorticoid receptor (GR) undergoes CRT-dependent 
nuclear export [Holaska et al., 1998; Holaska et al., 2001] mediated through its highly 
conserved DNA binding domain (DBD) [Black et al., 2001]. However, the extent to 
which CRT functions as an export receptor has remained a subject o f debate since its 
primary role is in the quality control of protein folding in the ER. In addition to this 
process, CRT has been implicated in an increasing number of critical cellular processes
* • 9 4 -including regulation of Ca homeostasis [Mery et al., 1996; Krause and Michalak, 1997; 
Holaska et al., 2002], integrin-mediated cell adhesion, [Leung-Hagesteijn et al., 1994; 
Coppolino and Dedhar, 1997; Li et al., 2005], numerous roles in immune response 
[Donnelly et al., 2006; Bohlson et al., 2006], and cardiac muscle development [Mesaeli et 
al., 1999; Lozyk et al 2006; Hattori et al., 2007].
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As noted above, a widely used technique to study the subcellular trafficking of 
nuclear receptors has been the interspecies heterokaryon assay [Bunn et al., 2001; 
Chandran and DeFranco, 1992; Black et al., 2001; Madan and DeFranco 1993; Maruvada 
et al., 2003; Hache et al., 1999; DeLong et al., 2004]. Recently, it has been reported that 
the polyethylene glycol (PEG) induced fusion of the cytoplasm during this assay disrupts 
the endoplasmic reticulum (ER), thereby causing a transient elevation in cytosolic CRT 
levels as the protein is released from the ER lumen. This fusion process may alter the 
export kinetics o f some shuttling proteins. For example, in contrast to the rapid shuttling 
o f GR observed in heterokaryon assays [Madan and DeFranco, 1993; Black et al., 2001], 
GR shuttling was found to occur only slowly over a period of hours during fluorescence 
recovery after photobleaching (FRAP) experiments in monokaryons [Walther et al.,
2003]. Moreover, in contrast to heterokaryon fusion experiments in which GR shuttling 
was shown to be CRT-dependent [Black et al., 2001], slow GR recovery in experiments 
other than heterokaryon fusions was shown to occur in a CRT-independent manner 
[Walther et al., 2003b]. Given these results, the question has arisen as to whether CRT- 
dependent nuclear export occurs under physiological conditions or merely in response to 
exogenous environmental stresses such as cell fusion.
With these data in mind we sought to ascertain whether TRo: shuttles under 
physiological conditions and, if so, whether it utilizes a CRT or CRM 1-dependent nuclear 
export pathway. To this end, we used a combined approach o f in vivo FRAP experiments 
and in vitro digitonin permeabilized cell nuclear export assays. Taken together, our in 
vivo and in vitro data point to the intriguing possibility that TRa? utilizes a cooperative
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export pathway involving the formation of a trimeric export complex in which CRT binds 
directly to TR a and serves as an adapter for CRM1 binding of TRa.
METHODS
Plasmids - The plasmid pGFP-TRa encodes a functional GFP-TRa fusion protein 
expressed under human cytomegalovirus (CMV) promoter control. This plasmid was 
constructed by subcloning the PCR product of rTRal (rat) cDNA into the enhanced GFP 
expression plasmid pEGFP-Cl (CLONTECH Laboratories, Inc. Palo Alto, CA) using 
Sacl and BamHl enzymes [Bunn et al., 2001].
The plasmid pGFP-GST-NES-NLS was a gift from R. Hache (University of 
Ottowa, Ottowa, Ontario) and contains the classic HIV-1 Rev NES sequence cloned into 
XhtApal site of pGFP-GST-NLS, a plasmid that includes the sequence o f the classic 
Simian virus 40 (SV40) large T antigen NLS at the 3’ end (described further in Walther 
et al., 2003b.) The plasmid pGEX-CRTwt was a gift from B. Paschal and encodes full 
length calreticulin subcloned into the pGEX-KG vector for over expression in bacteria 
[Holaska et al., 2001].
Cell Culture - HeLa cells (ATCC CCL-2) were cultured in MEM supplemented with 
10% fetal bovine serum (Invitrogen, Carlsbad, CA) containing penicillin 
(10,000Uml)/streptomycin (100 ^ig/ml), at 37°C under 5% CO2  and 98% humidity. K41 
(crt -/-) and K42 (crt +/+) cells were a generous gift from M. Michalak [Guo et al., 2002]. 
These mouse embryonic fibroblasts were cultured in DMEM with 10% calf serum under 
similar conditions. Cells were grown to 70-90% confluency.
Transient Transfection and Live Cell Imaging - For transient transfections, cells were 
seeded at 4-7 x 105 cells per 60mm vented dish (Nunc, Rochester, NY) onto 5 cm
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coverslips. Twenty-four hours after seeding, cells at 40-60% confluency were transfected 
with 4 fig plasmid DNA and 20 fi\ Lipofectamine Reagent (Invitrogen) in Opti-MEM I 
Reduced Serum Medium (Invitrogen) according to the manufacturer’s protocol. Reduced 
serum medium was replaced with complete medium 16-18 hours post-transfection.
After transfection, cells were used for microscopy within 48 h. Prior to mounting 
in an enclosed perfusion chamber (Bioptechs, Butler, PA), coverslips were incubated in 2 
ml complete media containing 100 figjm\ cycloheximide (Sigma, St. Louis, MO), 
penicillin (10,000Uml)/streptomycin (100 fig/m\), and 2-4 nM leptomycin B (LMB) 
(Sigma) or with vehicle (0.1% methanol) for 30 min. Coverslips were then washed with 
2ml Dulbecco’s phosphate buffered saline (D-PBS) and mounted. For the duration of 
each experiment, cells were incubated in MEM or DMEM containing 50 fig/m\ 
cycloheximide, penicillin (5,000 Uml)/streptomycin (50 /zg/ml), and 2-4 nM LMB or 
vehicle (0 . 1 % methanol).
Images were collected from an inverted Nikon ECLIPSE TE 2000-E fluorescence 
microscope (Sigma, Melville, NY) equipped with a Radiance 2100 laser scanning unit 
using a 60X 1.2 NA water objective (Nikon). The 488-nm line of a krypton-argon laser 
with a band-pass 515-530 nm emission filter was used for GFP detection and images 
were obtained using the time-course module of Laser Sharp 2000 
(Ziess,Thomwood,NY).
FRAP was recorded to analyze shuttling of proteins between nuclei within 
monokaryons. All FRAP experiments were performed in a temperature-controlled setting 
using a FCS2 live-cell chamber heating system and objective heater system (Bioptechs) 
to maintain 37°C. After the appropriate temperature was reached, a preexposure image
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was recorded from an area containing a multinucleated GFP-expressing cell using 2-8% 
laser power from the 488 nm line of a krypton-argon laser. One nucleus within the 
monokaryon was exposed at 50% laser power for two cycles using the same laser. After 
this bleaching exposure, sequential images were taken every 5 min for 11 cycles. To 
minimize undesired photobleaching, low laser intensities of 2 -8 % were again used for 
post-bleach images. For quantitative analysis of digitized images, fluorescence intensity 
values were generated using ImageJ (NIH). Bleached and unbleached nuclei were each 
considered as independent regions of interest. In addition, these values took into account 
the background brightness levels during each experiment. Intensity values were 
subsequently normalized so that the total fluorescence within each monokaryon after 
bleaching was equal to one. Graphs were generated using Microsoft Excel.
Heterokaryon Assay - For the preparation of heterokaryons, crt-l- cells (K42) were 
seeded at 2-2.5 xlO 5 cells/well onto coverslips in six-well dishes. Cells were then 
transfected with a GFP-TRa expression vector. Twenty-four hours post transfection of 
the crt-l- cells, human HeLa cells were trypsinized and resuspended in heterokaryon 
growth medium containing 70% DMEM, 10% FBS, and 20% sterile distilled water. The 
resuspended cells were then plated on the same coverslips at 5-6x105 cells/well. The cells 
were then incubated for 2.5 h in the presence o f cycloheximide at 50 /xg/ml followed by 
30 min in media with cycloheximide at 100 /Jg/ml at 37°C to allow adherence. 
Subsequently, the cells were rinsed with D-PBS. For cell fusion, coverslips were placed 
on 100 fi\ drops of warm 50% polyethylene glycol 1500 (Roche Applied Science, 
Indianapolis, IN) and incubated for exactly 2 min. Each coverslip was then rinsed with D-
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PBS and incubated for 2 h at 37°C in heterokaryon growth media containing 100 /zg/ml 
cycloheximide.
Following incubation, the cells were rinsed with D-PBS and then fixed for 10 min 
in 3.7% formaldehyde. After three 5 min washes with D-PBS, the cells were 
permeabilized using 0.2% Triton X-100. Following three 5 min washes with D-PBS the 
cells were incubated in 200 /d 1.5% normal goat serum for 20 min. The cells were then 
washed with D-PBS and incubated for an additional 20 min in 1.5% normal goat serum 
containing 0.5U/ml rhodamine-phalloidin (Molecular Probes, Eugene, OR) in order to 
visualize actin. Following a wash in D-PBS, the cells were then incubated for 10 min in 
D-PBS containing 10 jug/ml Hoechst 33258 (Sigma) to visualize DNA. Finally, the 
coverslips were mounted on slides using Gel/Mount mounting media (Biomeda, Foster 
City, CA). Slides were examined by fluorescence microscopy and images were obtained 
with a Cool SNAP HQ2  CCD camera (Photometries, Tucson, AZ) and NIS-Elements 
software (Nikon).
Antibody Staining- Cells were grown to 80-90% confluency and plated at 2x l05 cells/well 
onto coverslips in six-well dishes (Nunc). 24 h post-plating, coverslips were incubated in 
2nM LMB or 0.1% methanol for 5 h. The cells were then fixed and permeabilized. After 
fixation and permeabilization, cells were incubated in 1.5% normal goat serum in D-PBS 
for 30 min. The cells were then washed in D-PBS and probed for lh  in blocking solution 
containing rabbit polyclonal anti-CRT antibodies (Stressgen, Ann Arbor, MI) diluted to 
1:1000. Cells were then washed in D-PBS three times for 5 min each prior to incubation 
for lh  with FITC-conjugated goat anti-rabbit IgG (Vector Laboratories, Burlingame,
CA) diluted tol:600. After incubation the cells were washed in D-PBS and mounted
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using Gel/Mount containing 4 ’,6-Diamidine-2’phenylindole dihydrochloride (DAPI) 
(Sigma) (0.5pg/ml). CRT staining was visualized by fluorescence microscopy.
Nuclear Extractions- Cells were plated at 1 -2x 107 and grown for 24 h to confluence in 
100mm vented dishes. Cells were rinsed 3 times in D-PBS and nuclei lysed in 1 ml of 
Cell Lysis Solution (lOmM Hepes pH 7.9, lOmM KC1, lOmM EDTA pH 8.0, 0.4% 
IGEPAL (Sigma), 0.5mM phenylmethylsulfonyl fluoride (PMSF) (Roche), ImM 
dithiothreitol (DTT) (Omnipur, Gibbstown, NJ), Complete Mini EDTA-free Protease 
Inhibitor Cocktail Tablet (1 tablet/10 ml) (Roche) for 10 minutes at 4°C. The lysed cells 
were scraped and sheared by four passages through a 21G needle. Nuclei were pelleted 
by a 5 s pulse spin (200 X g) at 4°C in a microfuge. The cytoplasmic fraction was 
collected and the nuclei were washed twice with 1ml of extraction solution. A small 
fraction of the resuspended nuclei from the last wash was observed by differential 
interference contrast (DIC) to confirm that the nuclei had remained intact. The nuclear 
proteins were then extracted with lOOpl of Nuclear Extraction Solution (20mM Hepes pH 
7.9, 0.4M NaCl, lOmM EDTA pH 8.0, 10% glycerol, 0.5mM PMSF, ImM DTT, 
Complete Mini EDTA-free Protease Inhibitor Cocktail Tablets (1 tablet/10 ml)). Proteins 
from nuclear and cytoplasmic fractions were then analyzed by western blot.
Western Blotting- The approximate concentration of total protein in nuclear and 
cytoplasmic samples was determined by absorption at 280nm. For cytoplasmic and whole 
cell extract, 40pg o f protein were analyzed per lane, 40-60pg per lane were used for 
nuclear extracts, and 0.5-2pi of rabbit reticulocyte lysate (RRL) (Promega, Madison, WI) 
were analyzed. The samples were separated by 8% SDS-PAGE and transferred to PVDF 
membranes (Amersham) by semi-dry electro-blotting (Bio-Rad). The membranes were
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incubated overnight in the presence of blocking solution (TBS, 1% BSA, 0.1%
Tween 20). After six washes with TBS, the membranes were incubated with the primary 
antibodies for one hour. For the detection of CRT and 13- tubulin both rabbit polyclonal 
anti-CRT antibodies (SPA-600D, Stressgen) and rabbit polyclonal anti-/3- 
tubulin antibodies (Affinity Bioreagents, Golden, CO) were mixed together in blocking 
solution at 1:20,000 and 1:200, respectively. For the detection of CRM1 and CRT, 
Western blots were incubated separately with anti-CRM 1 (ABR) or anti-CRT (Stressgen) 
antibodies at 1:200 or 1:20,000, respectively. The blots were then washed six times with 
TBS and incubated with a horseradish peroxidase-conjugated goat anti-rabbit IgG (GE 
Healthcare) at 1:30,000 for one hour in blocking solution. Following this incubation, the 
blots were washed again six times and incubated with ECL-Plus detection reagent (GE 
Healthcare). Subsequently, the blots were analyzed using a Storm 860 Molecular Imager 
scanner (GE Healthcare) and ImageJ (NIH).
Protein overexpression - Plasmids coding for the protein of interest were transformed 
into competent E-coli (BL21 DE3-RI1) (Stratagene, La Jolla, Ca), per the manufacturer’s 
protocol, and grown to an OD6 0 0  o f 0.6-0.8 at 37°C. Expression was induced with 0.5mM 
IPTG (Isopropyl-b-D-Thiogalactoside) (Fisher Scientific, Pittsburgh, PA) and grown 3- 
5h at 30°C. Post-expression cultures were centrifuged at 1700 X g for 15 min at 4°C; 
bacterial pellets were stored at -80°C prior to protein purification.
GST protein purification - Bacterial pellets were resuspended in 10 ml B-PER® Bacterial 
Protein Extraction Reagent (Pierce, Rockford, IL), 1 ml 5.0 mg/ml lysozyme (Fisher) 
lOmM Tris, pH 8.0, and one Complete Mini EDTA-free Protease Inhibitor Cocktail 
tablet (Roche). Resuspended pellets were incubated on ice for 30 min. The pellets were
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subsequently sonicated (Sonic Dismembrator Model 100; Fisher) on ice to fully lyse the 
bacteria. The lysed mixture was then centrifuged at 17,950 X g 15 min at 4°C, and the 
supernatant was applied to 200pi of 50% Glutathione Sephrose 4B resin (GE Healthcare). 
Samples were incubated for 60 min at 4°C with gentle rotation, then centrifuged for 5 min 
at 500 X g at 4°C to pellet the resin. The resin pellet was washed 3 times with 10 ml ice 
cold PBS (140 mM NaCl, 2.7 mM KC1, 10 mM Na2H P04, 1.8 mM KH2P 0 4, pH 7.3) and 
then transferred to a Microfilter Spin Column (Pierce) and washed an additional 2 times 
with 600pl ice cold PBS. lOOpl Glutathione Elution Buffer (lOmM glutathione) was 
added to the column, incubated at room temperature for 2-4 min with agitation, then 
centrifuged at 700 X g for 30 sec at 4°C to collect eluted protein. The elution step was 
repeated 3X. The eluted fractions were pooled and dialyzed (Slide-A-Lyzer® Mini 
Dialysis Units, 7000MWCO, Pierce) against D-PBS overnight at 4°C. Protein samples 
were then concentrated using Micron Ultracel YM-30 Centrifugal Filter Devices 
(Millipore, Bedford, MA). Concentrated protein samples were analyzed by SDS-PAGE 
and protein concentration estimated using a NanoDrop® ND-1000 full-spectrum UV/Vis 
Spectrophotometer. Samples were stored at -80°C.
Permeabilized cell nuclear export assays - HeLa cells were seeded on 22mm Coverslips 
for Cell Growth™ (Fisher) in 6 well culture dishes (Nunc) at a concentration of 2-3x105 
cells per well. 24 hours post-seeding each well was transiently transfected with 2 fig 
plasmid DNA and lOpl Lipofectamine reagent (Invitrogen) in Opti-MEM I Reduced 
Serum Medium, and incubated 12-16 h. After 12-16 hr Opti-MEM I was replaced with 
MEM containing 10% fetal bovine serum for 4 hours. After 4 h cells were washed 3X 
with 2ml per well ice-cold export buffer (20 mM HEPES, pH 7.3, 110 mM KOAc, 5 mM
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NaOAc, 2 mM Mg(OAc)2 , 1 mM EGTA, 2mM DTT, ImM PMSF, Complete Mini 
EDTA-free Protease Inhibitor Cocktail tablet (1 tablet/10 ml) (Roche), then 
permeabilized with (50pg/ml) digitonin (Calbiochem, San Diego, CA) in export buffer 
for 4.5 min. Cells were then rinsed IX with 2ml per well ice-cold export buffer for 10 
min. Coverslips were then inverted over 50pl drops of export reaction mix (energy 
regeneration system composed of 5 mM creatine phosphate, 20 U/ml creatine 
phosphokinase, 0.5 mM ATP, 0.5 mM GTP, 5x export buffer, 670 nM GST-CRT, and 
25/d RRL) on parafilm in a moist chamber for 30 min at 30°C. Cells were then fixed in 
3.7% formaldehyde (Fisher) for 10 min followed by a 5 min rinse with export buffer. 
Coverslips were subsequently mounted on slides with 8 pi GelMount with DAPI 
(0.5pg/ml), and viewed by fluorescence microscopy.
RESULTS
TRa Shuttling in Living Cells is Leptomycin B Sensitive — The thyroid hormone receptor 
is a dynamic protein that shuttles rapidly between the nucleus and cytoplasm in 
heterokaryon assays. This shuttling is not blocked by LMB in heterokaryons, indicating 
that TRa: is exiting the nucleus by a CRM 1-independent pathway in this assay (Bunn et 
al., 2001).The heterokaryon assay involves PEG-induced fusion of the cytosols of 
transfected cells of one species (e.g. mouse) with untransfected cells of another species 
(e.g. human). Movement of the protein of interest can then be monitored from the nuclei 
o f transfected cells into the shared cytosol of the fused cells and, subsequently, into the 
nuclei of the opposing species. The recent finding that PEG-induced cell fusion causes 
changes in the cellular environment including a transient elevation in CRT levels
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[Walther et al., 2003b] has called into question the validity and interpretation of previous 
heterokaryon experiments.
We first sought to determine whether TRa shuttles under physiological conditions 
by performing experiments in living cells, independent of heterokaryon formation. In 
order to maintain physiological conditions, we used a fluorescence recovery after 
photobleaching (FRAP) assay in mulitinucleate live cells (monokaryons) to monitor the 
movement of GFP-TRa from unbleached to bleached nuclei. Unlike in heterokaryons, a 
monokaryon system does not require cell fusion or other manipulation which would 
compromise the integrity of the ER and thus, presumably, maintains low levels of 
cytosolic CRT. Transfected monokaryons were selected and one nucleus within these 
cells was exposed to intense laser illumination. This exposure resulted in loss of 
fluorescence within the selected nucleus due to irreversible photobleaching of the GFP 
fluorophore. The initial bleaching did not, however, result in loss o f fluorescence to 
neighboring nuclei within the same cells (Fig. 1). A series of images was taken for each 
individual experiment in which fluorescence recovery to bleached nuclei was measured 
and compared to the concomitant decrease in intensity within unbleached nuclei. Through 
image analysis and plotting of these fluorescence intensity data, we were able to 
determine the relative degree o f nucleocytoplasmic shuttling within particular cell types 
and treatments. Specifically, we assayed for T R a shuttling in human HeLa and mouse 
crt+/+ cell lines, both o f which express CRT. We show that, in contrast to the slow 
nuclear export observed of GR in COS7 cells [Walther et al., 2003b], TR a in fact shuttles 
rapidly between nuclei in both HeLa and crt+/+ monokaryons. These data are in close 
agreement with those observed for TR a shuttling kinetics in heterokaryons [Bunn et al.,
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2001] and suggest that TR a may play an as yet unknown role in cytosolic signaling 
pathways. After confirming that TR a rapidly shuttles between nuclei in these cells (Fig. 
1), we sought to determine whether TR a follows a CRM1 or CRT-dependent nuclear 
export pathway.
Based on our previous data showing that TRa nucleocytoplasmic shuttling is not 
blocked by LMB in a heterokaryon system [Bunn et al., 2001], we predicted that we 
would observe rapid shuttling of TR a between nuclei when HeLa and crt+/+ 
monokaryons were treated with LMB. Surprisingly, we saw only slow recovery of TRa 
within photobleached monokaryon nuclei of both cell types during FRAP experiments 
(Fig. 1). In contrast to previous data for heterokaryons in which near complete 
equilibration between nuclei was seen over the course of 1 hour [Bunn et al., 2001], 
recovery of fluorescence to bleached nuclei within live monokaryons treated with LMB 
was limited to only 22% (± 3%) for HeLa cells and 14% (± 2%) for crt+/+ cells over a 
similar time course (Fig.l). These results are in sharp contrast to parallel FRAP 
experiments performed in the absence o f LMB, during which TR a shuttling was much 
more rapid. In these experiments recovery to the bleached nuclei was measured at 56% (± 
4%) equilibration for HeLa cells and 88% (± 2%) equilibration for crt+/+ cells over 1 
hour (Fig. 1). To graphically illustrate the sensitivity of TR a nucleocytoplasmic shuttling 
to LMB, mean brightness values for photobleached and unbleached nuclei were plotted 
as a function o f time post-bleach. Fluorescence intensity was normalized so that the 
overall fluorescence o f bleached and unbleached nuclei was equal to 1.0 (arbitrary units). 
After normalization, convergence of the representative curves for bleached nuclei and 
unbleached nuclei towards one another represents the degree of fluorescence
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equilibration between these compartments. When one bleached and one unbleached 
nucleus are present, complete equilibration occurs at 0.5 units fluorescence.
To ensure that any recovery in GFP signal to bleached nuclei occurred as a result 
o f nucleocytoplasmic shuttling and not as a result o f de novo protein synthesis, all 
experiments were performed in the presence of cycloheximide. Differential interference 
contrast (DIC) microscopy was also performed to visualize monokaryon borders, thereby 
confirming that the experiments in which no shuttling was observed were conducted in 
cells which were, indeed, monokaryons as opposed to adjacent independent cells.
Taken together, these data show that TR a nuclear export is LMB-sensitive, 
suggesting that in live, unfused cells the CRM1 pathway plays a role in mediating export 
of T R a  One possible explanation for these unexpected results is that the heterokaryon 
system utilized previously to assay for CRM1 dependence [Bunn et al., 2001] creates an 
artificial environment in which the effects of deactivating CRM1 activity are 
overshadowed by cell fusion-dependent upregulation of alternative export factors such as 
CRT. With this possibility in mind, we sought to determine whether CRT is used as an 
alternative nuclear export receptor by TR a in vivo.
TRa Shuttling is Inhibited in Living Cells Deficient in CRT Expression — CRT has 
previously been shown to function as an exportin for nuclear receptors related to TRa: 
[Holaska et al., 1998; Holaska et al., 2001; Black et al., 2001; Prufer and Barsony, 2002]. 
To address the question o f whether TR a export is also mediated by CRT, we transiently 
transfected mouse embryonic fibroblast cells isolated from CRT knockout mouse 
embryos (crt-/- cells) [Mesaeli et al., 1999] with GFP-TRaand monitored FRAP in 
bleached nuclei of transfected CRT-deficient monokaryons. Although nuclear import of
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both the tumor suppressor p53 and the transcription factor NF-AT3 are impaired in cells 
deficient in CRT expression, other shuttling proteins including GR and GATA4 are 
unchanged in their import properties regardless of whether CRT is present [Mesaeli and 
Phillipson, 2004]. Thus, the altered nuclear import of some proteins in 
crt-/- cells is a specific effect and is not indicative of a general defect in the import cycle. 
Nuclear import of TR a was not impaired in crt-/- cells, indicating that CRT is not 
required for its nuclear localization.
Although TR a localized normally to crt-/- cell nuclei prior to FRAP, we observed 
a striking reduction in its nucleocytoplasmic shuttling after photobleaching (Fig. 2). 
Indeed, only 14% (± 2%) fluorescence equilibration from unbleached nuclei to bleached 
nuclei was seen in the crt-/- cell line. In contrast, HeLa cells and crt+/+ cells not treated 
with LMB showed 56% (± 4%) and 88% (± 2%) fluorescence equilibration with 
unbleached nuclei, respectively (Fig. 1). To demonstrate that the lack of CRT in these 
cells was not responsible for any non-specific action preventing all nucleocytoplasmic 
shuttling, crt-/- cells were also transfected with a shuttling control construct, pGFP-GST- 
NES-NLS. The fusion protein localizes to the nucleus at steady state and shuttles via a 
CRM 1-mediated nuclear export pathway [Walther et al., 2003b]. As expected, shuttling 
of this protein was not inhibited in crt-/- cells, indicating that the CRM1 pathway is 
functional in these cells (t Vi < 10 min) (Fig. 3). Taken together, these data thus support 
the hypothesis that TR a can utilize a CRT-mediated nuclear export pathway.
CRT is Localized to the Cytoplasm and Nuclei o f  Various Cell Types -  Previously, CRT 
was believed to reside solely in the ER. Recently, however, increasing numbers of reports 
have identified small fractions of CRT in both the cytosolic and nuclear compartments of
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various cell lines in addition to its primary location within the ER [Jethmalani et al.,
1997; Sharma et al., 2004; Kobayashi et al., 2006]. To assess whether a detectable 
population of CRT was localized to the nuclei of the cells used in our study, we isolated 
nuclei by biochemical fractionation and analyzed the cellular fractions obtained by 
Western blot. The cellular extracts were probed simultaneously with anti-CRT and anti-/? 
tubulin, which was used to normalize the data. When comparing the amount of CRT in 
the nuclear fraction to the amount of tubulin, a strictly cytoplasmic protein, we found that 
the nuclear fraction of HeLa cells was significantly enriched in CRT (p<0.001) (Fig. 4). 
In HeLa cells, the ratio between CRT and tubulin increased from 1.7 ± 0.3 in the 
cytoplasm to 9.6 ± 4.2 in the nucleus indicating that the amount of CRT observed in the 
nuclear fraction is not a result o f cytoplasmic contamination during the extraction. These 
results were also significant in crt+/+ cells (p<0.001) (Fig. 4). In these cells, the ratio 
between CRT and tubulin increased from 1.3 ± 0.1 to 2.3 ± 0.7 in the cytoplasmic and 
nuclear fractions, respectively. Together these data provide further evidence that CRT is 
present in a small but significant nuclear fraction within the cell lines used for our 
experiments. To further demonstrate that CRT is localized to multiple cellular 
compartments, we performed indirect immunofluorescence assays. Consistent with the 
Western blot analysis a small population of nuclear CRT was observed in addition to a 
more prominent cytoplasmic pool (Fig. 4).
TRa nuclear export is partially inhibited by treatment with LMB (Fig. 1). This 
suggests a role for CRM 1 in TR a shuttling in addition to that played by CRT and points 
to a possible interplay between CRT and CRM1. A direct interaction between CRT and 
CRM 1 could, in theory, induce a shift in CRT towards the nucleus upon treatment with
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LMB which would be indicative of CRM1 sequestering CRT in this compartment (Fig. 
4). To test this, we treated cells with LMB and performed immunostaining for CRT in 
situ. This treatment did not, however, induce a detectable shift in the subcellular 
localization of CRT towards the nucleus.
Polyethylene Glycol Induced Heterokaryon Formation Restores TRa Export From CRT- 
Deficient Cell Nuclei -  Having shown that GFP-TRa nuclear export is impaired in crt-l- 
cells (Fig. 2), we sought to test whether TR a export could be restored by the addition of 
exogenous CRT. To do so, we transfected crt-/- cells with GFP-TRa and then fused them 
with untransfected HeLa cells. Since PEG-induced heterokaryon formation causes a 
transient elevation in cellular CRT levels [Walther et al., 2003b], we hypothesized that if 
TR a utilizes CRT for nuclear export that the fusion process would restore export in crt-/- 
cells. This could occur either as a result o f CRT release from the HeLa cell ER or, 
alternatively, from the relatively low CRT levels present within HeLa cell nuclei and 
cytosol prior to fusion. Experiments were performed in the presence of cycloheximide in 
order to inhibit de novo protein synthesis. Consistent with our prediction, we found that 
TR a was capable of exporting from crt-l- nuclei into the shared cytosol and subsequently 
reimporting into HeLa nuclei in these heterokaryon assays (Fig. 5). Taken together, the 
results from these heterokaryon experiments and our live-cell FRAP experiments support 
the hypothesis that TR a utilizes CRT as a nuclear export receptor.
Efficient Nuclear Export o f  TRa in Permeabilized Cells Requires Cytosol and CRT - To 
provide further evidence for a role of CRT in the nuclear export of TRa, we performed 
permeabilized cell in vitro nuclear export assays utilizing purified recombinant GST- 
CRT. For this assay, HeLa cells were transiently transfected with a GFP-TRa expression
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plasmid. GFP-TRa displays a complete and strong nuclear fluorescence sixteen hours 
post-transfection. At this point the outer cell membrane was permeabilized with digitonin 
and export reactions were performed. First, we sought to assess whether exogenous CRT 
was sufficient to induce nuclear export of TRa. Our results showed no observable change 
in TR a nuclear localization between 0 min and 40 min irrespective of varying CRT 
concentration from 270nM-l/zM. During this period, all TR a remained localized to the 
nucleus (Fig. 6).
To determine whether additional factors were required to either permit nuclear 
import o f CRT or to aid in the nuclear export of TRa in conjunction with CRT, export 
reactions containing CRT and a cytosol mixture (rabbit reticulocyte lysate, RRL) alone or 
a combination of CRT and RRL were similarly assayed at 0 minutes and 40 minutes.
RRL is commonly used as a source of cytosol for nuclear import and export assays 
[Adam et al., 1990]. Initially, we tested RRL alone. As expected, at to TR a was localized 
to the nucleus. At Lo a moderate level o f export was observed as indicated by a decrease 
in GFP-TRa fluorescence in the nuclei compared with to (>80% loss of fluorescence) 
(Fig.6). Upon addition of RRL and CRT in combination, however, we observed a striking 
increase in the nuclear export of TR a as compared to that which was observed for RRL 
or CRT individually. Indeed, over a similar time course nuclear export was nearly 
complete (>95% fluorescence loss) (Fig. 6). These data suggest that an additional factor 
(or factors) present in cytosol interacts cooperatively with CRT to mediate efficient 
nuclear export o f T R a
The GTPase Ran plays an integral role in the shuttling o f many transcription 
factors and exists predominantly in a GTP-bound state within the nucleus. In this
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conformation, RanGTP participates in the formation of export complexes containing the 
classical leucine-rich NES [Weis, 2003; Fried and Kutay, 2003; Pemberton and Paschal, 
2005; Cook et al., 2007]. In addition, it also stabilizes protein kinase inhibitor (PKI)-CRT 
interactions as well as enhances CRT-dependent nuclear export of PKI in permeabilized 
cells [Holaska et a l, 2001]. It has been shown in permeabilized cell nuclear export assays 
that residual nuclear RanGTP remaining in cells after permeabilization was sufficient to 
permit CRT-dependent nuclear export [Holaska et al., 2001]. To determine the role of 
Ran in the nuclear export of TRa, we performed assays with recombinant CRT in the 
absence of RanGTP or having supplemented the system with 1.9/zM RanGTP. We did 
not, however, observe any difference in TR a nuclear localization between these 
conditions; TR a remained localized to the nucleus in either case (data not shown). This 
suggests that RanGTP is not the limiting factor for TR a nuclear export.
Several factors may play a role in stabilizing CRT-cargo interactions, inducing a 
conformational shift in CRT, or in other non-specific functions. Calcium, for example, 
modulates CRT conformation within the lumen of the ER [Corbett et al., 2000] and also 
regulates CRT function as a chaperone for the T-cell protein perforin [Andrin et a l,
1998]. In addition, Ca2+ enhances CRT-mediated nuclear export of GR-GFP but,
• 9 4 -interestingly, excess Ca also inhibits classical NES-regulated nuclear export of Rev- 
GFP in vitro [Holaska et a l, 2002]. We supplemented permeabilized cell export assays 
with 20mM Ca2+ in the presence o f CRT but observed no difference in TR a nuclear 
localization. Under these conditions TR a remained localized to the nucleus (data not 
shown). These results suggest that Ca2+ also is not the limiting factor required for nuclear 
export in these assays.
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Based on our findings in live cells that the nuclear export of TRa shows partial 
CRM 1-dependence (Fig. 1), we performed Western blot analysis to test whether CRM1 
was present in RRL and could be the additional factor required for CRT-dependent 
nuclear export. Our data show that CRM1 was present in RRL and HeLa cell extract, 
while CRT was detected only in HeLa cell extract and was absent from RRL (Fig. 7). 
These findings point to the possibility that CRM 1 could be the additional factor 
accounting for the enhanced export of TR a in in vitro export assays supplemented with 
RRL. A CRT:CRM1 interaction also accounts for the observation that TR a is not 
exported as efficiently from nuclei treated with RRL, as CRT is absent from this 
exogenous cytosol.
DISCUSSION
Here, we present findings that provide evidence for a previously uncharacterized 
mechanism for the dynamic shuttling of TRa. We have used a combination of in vivo 
FRAP experiments and in vitro digitonin permeabilized cell nuclear export assays of 
transiently transfected cells to investigate aspects of TRa subcellular trafficking. Taken 
together, these data suggest a novel export mechanism in which CRT, CRM1 and TR a 
form a trimeric complex which is exported from the nucleus.
We propose a nuclear export pathway in which CRT serves as an adapter between 
CRM1 and TRa, thereby promoting rapid nuclear export. Alternatively, when the CRM1 
pathway is blocked or CRT levels are increased under cellular stress, CRT can act 
independently as a less efficient exportin (Fig. 8). crt-/- cell lines fail to support nuclear 
export of TRa, suggesting that CRT is indispensable for TR a nuclear export. Thus, CRT
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may be the most important component of the TR a nuclear export pathway. These data 
suggest that CRT deficiency prevents CRM1 binding to TR a and inhibits both 
cooperative and autonomous TR a export as a consequence (Fig. 8).
Prior to this study, the role that CRT plays in nuclear export was a subject of 
debate. Previously, CRT was thought to reside permanently within the ER lumen where it 
participates in the maturation of newly synthesized proteins and sequesters Ca . In 
addition to its prominence in the ER, however, increasing numbers of reports have 
suggested that CRT may in fact be present in small fractions in other cellular 
compartments. For example, CRT appears to interact with a ubiquitin-like nuclear protein 
in the nucleus of rice cells [Sharma et al., 2004]. Moreover, CRT also localizes to the 
nuclear matrix of some carcinoma cells and assists in chromatin formation [Kobayashi et 
al., 2006]. All o f these data suggest that CRT is likely to possess an evolutionarily 
conserved ability to access the nucleus, where it appears to serve multiple functions. 
Recently, a mechanism involving the post-translational processing and retrotranslocation 
o f CRT from the ER to the cytoplasm has been identified, suggesting a potential pathway 
for CRT to subsequently gain access to the nucleus via import [Afshar et al., 2005].
Although low levels of CRT are found in multiple cellular compartments, the 
majority of CRT present in heterokaryons immediately after cell fusion comes as a result 
o f ER disruption and its release from the ER lumen [Walther et al., 2003]. While TRa 
export was inhibited in crt-/- monokaryons, rapid shuttling and fluorescence 
equilibration was observed between nuclei of heterokaryons. For CRT to mediate export 
of TR a from crt-/- nuclei, presumably it must first be imported into these same nuclei. 
Following import, CRT could then interact with TR a and facilitate its nuclear export. Our
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in vitro nuclear export assays suggest that while CRT is necessary for efficient export, 
there is also an additional factor in the cytosol required for its nuclear import, its role in 
the export of TRa, or both. Based on our in vivo FRAP experiments, our in vitro nuclear 
export assays, and our Western blot analysis of RRL composition, we suggest that this 
additional factor is the exportin CRM1.
In both HeLa and crt +/+ cell lines, TR a displayed rapid nucleocytoplasmic 
shuttling in the absence of LMB. Although the precise mechanism by which this export 
occurs remains to be determined, there are several potential explanations. CRT and 
CRM 1 could undergo a conformational shift which maximizes interaction with 
components of the nuclear pore complex, thus expediting the export process. 
Alternatively, binding of CRM 1 could increase the affinity o f CRT for TR a allowing for 
more efficient export. In any case, the fluorescence equilibration between bleached and 
unbleached nuclei in monokaryons of either cell type (HeLa t Vi = 40 min, crt+/+ t XA =
10 min) indicates that TR a shuttles rapidly under these conditions.
As treatment with LMB results in covalent modification of a critical cysteine 
residue within CRM1 [Kudo et al., 1999], this potential interaction with CRT may be 
abolished upon LMB treatment. As such, CRT may still be capable o f binding TR a and 
facilitating export, albeit to a lesser extent. This would explain our results in which TRa 
shuttling in HeLa and crt+/+ monokaryons occurs only slowly after treatment with LMB.
Finally, our model takes into account the cell fusion dependent release o f CRT 
during heterokaryon experiments [Walther et al., 2003b] and explains the stark contrast 
between LMB-insensitive TR a shuttling in heterokaryons [Bunn et al., 2001] versus 
LMB-sensitive shuttling in monokaryons [present study]. Although CRT may be the
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limiting factor in TR a nuclear export under normal circumstances, this limitation is 
countered by the increased efficiency of export resulting from cooperative binding of 
CRM1 (Fig. 8). While CRM1 is undoubtedly inactivated by LMB treatment in 
heterokaryons, the attenuated nucleocytoplasmic shuttling expected may not be observed 
due to the increased cytosolic levels of CRT resulting from PEG-induced cell fusion. 
Under these conditions, the relatively low levels of CRT found within the nucleus or 
cytosol under normal circumstances would be markedly increased and its low levels 
would no longer be limiting. Although, according to this model, autonomous CRT- 
mediated export o f TR a is not as efficient as cooperative export, the sheer increase in free 
CRT directly after cell fusion may be enough to overcome this deficiency and allow rapid 
nuclear export to proceed in the presence of LMB (Fig. 8).
Previously, the only support for the hypothesis that CRT mediates export of TR 
was the finding that the DNA binding domain (DBD) o f TR(3 is sufficient to confer 
nuclear export when fused to a GFP reporter. Given that the DBDs of TR/3 and GR share 
43% sequence homology, it is not unreasonable to propose that the TR(3 DBD could also 
interact directly with CRT, as has been shown for the GR DBD (Black et al., 2001). 
Examining the specific nucleocytoplasmic shuttling properties of TR a domains within 
CRT-deficient cell lines will provide valuable insight into the physical basis for TR a 
binding of CRT.
Most NESs bind CRM1 with low affinity and often require additional adapter 
proteins to serve as a bridge between CRM1 and the cargo protein being exported [Cook 
et al., 2007; Kutay and Guttinger, 2005]. For example, Ran-binding protein 3 (RanBP3) 
directly binds CRM1 in the nucleus and increases the affinity of CRM1 for NES
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containing cargo as well as RanGTP [Lindsay et al., 2001; Englmeier et al., 2001]. In 
addition, RanBP3 binding also maximizes the interaction of the CRM 1 export complex 
with nucleoporins of the NPC [Lindsay et al., 2001]. Similar conditions are observed for 
CRM 1 binding of other regulatory proteins which participate in nucleocytoplasmic 
shuttling. Although steroid receptor coactivator-1 (SRC-1) contains two clusters of 
hydrophobic amino acids similar to the classic leucine-rich NES associated with CRM1- 
mediated nuclear export, this protein failed to accumulate within the nuclei o f Cos-7 cells 
when these regions were mutated even though its export was sensitive to LMB [Amazit et 
al., 2003]. Presumably then, an unknown adapter protein which is recognized by both 
CRM1 and SRC-1 accounts for the nuclear accumulation of SRC-1 upon LMB treatment. 
Other examples include both the 60S and 40S ribosomal subunits of the yeast S. 
cerevisiae. These large complexes undergo CRM 1-mediated nuclear export in an adapter- 
dependent manner [West et al., 2007; Hedges et al., 2006; Seiser et al., 2006]. Such 
situations are analogous to our TRoj export pathway model in which CRT serves as this 
adapter protein.
The model presented here explains several previously anomalous observations 
relating to CRT, CRM1, and nuclear receptor export in general. There is certainly a 
discrepancy between the shuttling kinetics o f nuclear receptors in a heterokaryon system 
versus under other experimental conditions, such as those reported in Walther et a l 
(2003)b. Particularly striking is the disparity observed between protein shuttling in in 
vivo monokaryon experiments compared to the interspecies heterokaryon assay. Here, for 
the first time, the observation that some nuclear receptors such as TRa: [present study] 
and GR [Savory et al., 1999; Itoh et al., 2002] rely in part on CRM 1-dependent nuclear
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export can be reconciled with the observation that cell lines deficient in CRT expression 
but retaining their CRM1 activity fail to support nuclear export of the same proteins 
[Black et al., 2001; present study].
Interestingly, we have also shown that the p53 tumor suppressor protein displays 
highly reduced shuttling kinetics in crt+/+ monokaryons as compared to heterokaryon 
assays using HeLa and NIH/3T3 cells (unpublished results). Although the significance of 
this observation remains to be determined, these observations again highlight the 
complexity of nucleocytoplasmic transport pathways and point to a similar discrepancy 
between p53 shuttling under in vitro and in vivo conditions. As p53 undergoes nuclear 
export in a CRM 1-dependent manner [Freedman and Levine et al., 1998; Rittinger et al., 
1998; Lain et al., 1999; Stommel et al., 1999], this observation should be considered 
when designing experiments which attempt to utilize p53 as a control for CRM1 activity.
These data provide insight into the nuclear export pathway of TRa and suggest a 
possible mechanism by which other shuttling proteins may utilize complex and, to some 
extent, functionally redundant export modes involving both characterized pathways 
(CRM1) and a multitude of other chaperones. In addition, these results also represent a 
novel role in nuclear export for the functionally diverse protein CRT. Although more 
research will be necessary to precisely determine the significance of this cooperative 
export pathway, regulation of TR a target genes may be influenced in several ways. 
Inefficient TR a nuclear export in the absence of CRT could, for example, be indicative of 
an evolved compensatory mechanism to upregulate the transcription of genes involved in 
similar cellular processes as the numerous ones that have been identified for CRT. 
Conversely, rapid shuttling of TR a dependent on an intact cooperative export pathway
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may be representative of a general mechanism to clear shuttling transcription factors from 
the nucleus under physiological conditions. This putative trimeric export complex and 
nuclear export pathway may be relevant to related members of the nuclear receptor 
superfamily other than T R a  Identification of this export pathway and other mechanisms 
by which nuclear receptors exit the nucleus will contribute substantially to understanding 
the regulatory activity of these proteins. One challenge for the future will be to examine 
how regulation of this cellular compartmentalization is impaired or altered in the case of 
aberrant nuclear receptor expression. In addition, defining how nuclear export integrates 
TR a activity with other signaling pathways may provide important clues as to the mode 
of action o f mutant TRs which are responsible for a host of pathological conditions 
including cancer [Gonzales-Sancho et al., 2003; Cheng, 2003; Bonamy et al., 2005].
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FIGURE 1. TRa shuttling is inhibited by treatment with leptomycin B in live monokaryons 
expressing CRT, A, HeLa cells were transfected with GFP-TRa and nucleocytoplasmic shuttling was 
monitored through FRAP (n = 7). White arrowheads indicate bleached nuclei. Parallel experiments were 
performed in the presence of LMB (n = 6) to block CRM 1-mediated nuclear export and DIC images were 
taken to delineate cell borders. Fluorescence recovery graphs indicating relative shuttling of GFP-TRa were 
generated. Squares indicate relative fluorescence levels within unbleached nuclei and diamonds represent 
levels within bleached nuclei. Any apparent change in nucleus morphology is a result of cell movement 
over the course of the experiment. B, as in A using crt+/+ cell line (n = 10 -  LMB, n = 6 + LMB).
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FIGURE 2. TRa requires CRT for nuclear export. A, crt-/- cells were transfected with GFP-TRa and 
nucleocytoplasmic shuttling was monitored through FRAP (n = 8). White arrowheads indicate bleached 
nuclei. DIC images were taken to delineate cell borders and fluorescence recovery graphs indicating 
relative shuttling of GFP-TRa were generated.
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FIGURE 3. The CRM1 pathway remains active in crt-/- cells. A CRM1- dependent shuttling control 
(GFP-GST-NES-NLS) was transfected into crt-/- cells and nucleocytoplasmic shuttling was monitored by 
FRAP. White arrowheads represent bleached nuclei.
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FIGURE 4. CRT is localized to the cytosol and nuclei of various cell types. A, Nuclear and cytosolic 
from HeLa and crt+/+ cells were analyzed by Western blot, using anti-CRT and anti-p tubulin antibodies. 
Magic Marker (MM) size standard is indicated and crt-/- cells were used as a negative control. A 
representative blot for HeLa cells is shown. B, The ratio of CRT to tubulin increased significantly from 
cytosolic to nuclear fractions in both HeLa cells (n = 12) and crt+/+ cells (n = 13). C, HeLa cells cultured 
in the presence or absence of LMB were labeled with anti-CRT antibodies by indirect immunofluorescence.
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FIGURE 5. Polyethylene glycol (PEG)-induced cell fusion restores TRa export from CRT-deficient 
cell nuclei, crt -/- cells were transfected with GFP-TRa. Subsequently, HeLa cells were plated on the same 
coverslip and cytoplasmic fusion was performed using 50% PEG. Cells were fixed and protein localization 
was observed by fluorescence microscopy. Nuclei of crt-/- cells (speckled appearance) are indicated by 
white arrowheads. HeLa cell nuclei exhibit diffuse Hoechst staining. Heterokaryon borders are visualized 
by staining of actin with rhodamine-phalloidin.
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FIGURE 6. Nuclear export of TRa in permeabilized cells. A, GFP-TRa remains nuclear at t40 in the
presence of 670nM calreticulin (CRT). HeLa cells transfected with GFP-TRa were digitonin 
permeabilized, and incubated in an export reaction containing CRT, energy regeneration system, and export 
buffer alone. At t40 no GFP-TRa export was observed. B, Export reactions containing rabbit reticulocyte 
lysate (RRL), energy regeneration system, and export buffer were able to support >80% loss of nuclear 
fluorescence of GFP-TRa at t40. C, Export reactions containing both CRT and RRL were able to support 
>95% loss of nuclear fluorescence of GFP-TRa at t40. White values normalized using IPlab 3.55 @ 2000 
for A,B,C. D, Enlarged section from panel B t40 (*) and C t40 (**). White values for * from panel B and ** 
from panel C adjusted to 200 for low intensity visualization of the residual GFP-TRa in export reactions.
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FIGURE 7. Rabbit reticulocyte lysate (RRL) contains CRM1 but not CRT. HeLa whole cell extract and 
varying volumes of RRL were probed with anti-CRM 1 and anti-CRT antibodies and analyzed by Western 
blot. Magic Marker (MM) size standard is indicated.
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FIGURE 8. Model for nuclear export of TRa involving formation of a trimeric export complex with 
CRM1 and CRT. A, Trimeric nuclear export complex observed in cells expressing CRT (HeLa, crt+/+) in 
which CRT serves as an adapter protein for CRM1 binding of TRa. Although CRT levels are low under 
these conditions, export of TRa is efficient and rapid export is observed. B, Inefficient nuclear export of 
TRa in cells expressing CRT (HeLa, crt+/+) occurs upon treatment with LMB. CRM1 is inactivated but 
CRT can still support modest export autonomously. C, Rapid export of TRa occurs even in the presence of 
LMB upon PEG-induced heterokaryon fusion. Although the CRM1 pathway is inactivated, transient CRT 
release from the ER renders sufficient CRT levels to support rapid export of TRa. D, crt-/- cells do not 
support export of TRa because CRT is not present to serve as an adapter for CRM 1 binding of TR
0 3  TRa O CRT
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DISCUSSION
TR a is an important transcription factor which mediates the regulation of target 
genes in response to thyroid hormone. Understanding the mechanisms by which T R a and 
other TR isoforms interact with signaling pathways and the transcriptional machinery is 
crucial to establishing a basis for the treatment of numerous thyroid related disorders. 
Although it is known that T R a regulates transcription by binding DNA within the 
nucleus, characterization of other points at which T R a communicates with various 
signaling molecules is only in its infancy. One probable way in which TR a alters gene 
expression is through non-genomic functions in the cytosol. In addition, removal of TR a 
from the nucleus undoubtedly has an effect on the levels of T3 -induced transcriptional 
activation or, in the case of negative TREs, transcriptional repression. Investigation of the 
nuclear export pathway which T R a utilizes is critical to understanding these functions. 
Evidence presented in this thesis suggests a novel nuclear export pathway in which TR a 
utilizes two export receptors cooperatively for its nuclear export.
FUTURE DIRECTIONS
The research presented herein provides compelling evidence that CRT serves as 
an adapter protein for CRM 1 binding of TRa, thereby promoting TR a nuclear export. 
Furthermore, it appears that CRT is also capable of promoting the nuclear export of TR a 
in the case that CRM 1 is inactive, albeit to a lesser extent. In addition to furthering our 
understanding of TR a regulatory function, this novel nuclear export pathway may 
provide valuable insight into the modes of export for other shuttling transcription factors 
including related members of the nuclear receptor superfamily.
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Many questions remain as to the specific requirements which promote the 
assembly, transport, and disassembly of this novel trimeric export complex. In addition, 
gaining a better understanding of the structural characteristics which allow 
CRM 1 :CRT:TRo: binding will provide us with valuable insight into the evolutionary and 
molecular processes by which oncogenic homologues of TR a exert their effects. Finally, 
the increasing knowledge of CRT function in many cellular processes coupled with the 
observation that CRT may be involved in cellular stress response begs the question of 
how this protein’s expression and activity may alter transport under different 
environmental conditions. In addition to the experiments performed in completion of this 
thesis, several additional lines of in vitro and in vivo experimentation will be valuable in 
answering these questions and in supporting the proposed nuclear export pathway.
A number of experiments could be performed in order to show a direct interaction 
between the protein constituents of this trimeric export complex. Such an interaction 
would provide evidence that these proteins do, in fact, bind one another and would 
support the hypothesis that this complex forms within the nucleus. Performing in vitro 
pull-down assays, for example, could be useful in demonstrating a direct protein .-protein 
interaction. In theory, preparing a column in which some form of recombinant CRT (e.g. 
GST-CRT) is used as bait will allow visualization of binding to a prey protein such as 
His-tagged CRM1. To our knowledge, this binding assay has not been performed 
previously and, perhaps, will show conclusively that CRT interacts directly with CRM 1.
Despite their power in revealing protein:protein interactions, pull-down assays 
nevertheless exhibit disadvantages which are inherent in in vitro systems. The specific 
cellular conditions, binding partners, and potentially critical cofactors which promote
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assembly o f protein complexes such as CRMl:CRT:TRof are not always well 
characterized. As a consequence, factors which are potentially indispensable to particular 
protein:protein binding interactions may be unintentionally excluded from a designed 
pull-down system. The failure of CRM1 to bind CRT in an in vitro pull-down assay, 
therefore, would not disprove the existence of the interaction which has been 
hypothesized herein. To address this potential disadvantage, a number of additional 
factors could be added in addition to the prey protein. In particular, RanGTP and other 
Ran binding proteins (e.g. RanBP3) are known to influence the binding of export 
receptors to cargo proteins [Lindsay et al., 2001; Englmeier et al., 2001]. It is reasonable 
to speculate that introduction of these additional factors could have significant influence 
over the binding affinity of CRM1 for CRT or for CRT binding of TRa. Similarly, Ca2+ 
concentration influences the conformational state and protein binding characteristics of
2 d "CRT. Performing pull-down assays supplemented with varying amounts of Ca will be 
helpful in determining its potential role in CRT binding. Most importantly, perhaps, pull­
down assays involving CRM1 and CRT should be performed in the presence of purified 
TRa. If CRT does, in fact, bind to TR a as is hypothesized, this interaction may expose 
sites on CRT which are involved in CRM 1 binding but are not available in the absence of 
TRo.
In addition to in vitro pull-down assays, an alternative method of examining the 
potential binding of CRT to CRM 1 is to perform a yeast-two hybrid screen. Like a pull­
down assay, two-hybrid screens allow visualization of the interaction between proteins of 
interest. In this system, however, interaction is indicated by the expression of a reporter 
gene which is activated as a result o f protein:protein binding to its promoter region. This
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assay offers the advantage that it takes place within cells, thereby providing an 
environment which is more likely to present all of the necessary cofactors required for 
efficient binding.
TR a is comprised of several domains which confer its ability to bind DNA, react 
to thyroid hormone, and interact with other regulatory proteins. Importantly, these 
regions are also responsible for interacting with the transport machinery. The question 
remains, however, as to the location and specific characteristics of nuclear export 
sequences within TRa. Recently, our lab has engineered a panel of constructs in which 
individual TR a domains have been fused to fluorescent protein markers [M.S.
Mavinakere and L.A. Allison, unpublished results]. Transfection of these domain 
constructs into cells will allow the examination of each domain independently. Observing 
the localization of each construct will be helpful in determining which portions of TR a 
are involved in its subcellular localization. In addition, examining the potential nuclear 
export capability of domain constructs which are cytoplasmic at steady state may first 
require subcloning a NLS (e.g. SV40 T-NLS) into the domain constructs in order to 
initially localize those particular proteins to the nucleus. Subsequent mutagenesis of 
specific residues which are candidate NES amino acids will allow us to characterize 
which regions of T R a are most important for its nuclear export. For example, the DBD of 
a number o f nuclear receptors has been shown to interact directly with CRT in binding 
assays [Black et al., 2001]. In addition, a possible role in nuclear export has been 
proposed for the LBD of a number of shuttling proteins including the androgen receptor 
[Saporita et al., 2003] and the TR related oncoprotein v-ErbA [DeLong et al., 2004]. This 
analysis could be extended to consider the localization and shuttling of TR a domain
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constructs in the presence and absence of LMB and in cells which are deficient in CRT 
expression. Comparing the shuttling properties of these domain constructs in crt-/- cells 
versus control cells and in the presence of LMB will increase our understanding of how 
CRT and CRM1 interact with TRa.
CONCLUSIONS
Given its nearly ubiquitous expression in many higher eukaryotes, understanding 
the mechanisms by which thyroid hormone controls gene expression is of great 
importance. A major aspect of this understanding is to determine how TRs regulate T 3 -  
responsive gene expression. The pathway by which TR a exits the nucleus has not been 
investigated until now. A number o f proteins which are closely related to T R a utilize 
CRT as an exportin [Holaska et al., 2001] and can directly bind CRT through their DBD 
[Black et al., 2001]. In addition, several reports have implicated the exportin CRM1 in 
having at least some role in the nuclear export of nuclear receptors despite the absence of 
a leucine-rich NES in these proteins [Savory et al., 1999; Itoh et al., 2002]. The results of 
this thesis suggest a novel, cooperative nuclear export mechanism in which CRT serves 
as an adapter for CRM 1 binding of TRa. Moreover, CRT also appears to facilitate a 
limited amount of TR a nuclear export when CRM1 is inactivated by LMB treatment.
This pathway may be important in regulating gene expression by integrating TR a 
activity with various cytoplasmic signaling pathways. This work and future studies 
relating to nucleocytoplasmic transport of TR a will shed light onto the mechanisms by 
which T R a regulates gene expression under physiological conditions, and as to how its 
mislocalization may contribute to the onset of numerous diseases including cancer. In
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addition, these results have the potential to be of great importance to the study of nuclear 
transport o f other shuttling transcription factors including members o f the nuclear 
receptor superfamily.
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